Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
09/2005
09/21/2005CN1219771C Process for preparing 1, 5-diaryl-3-substituted pyrazoles
09/21/2005CN1219511C Method for curing sepsis
09/20/2005US6946474 Nitrogen-containing compounds and their use as glycine transport inhibitors
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085206A1 Indazole derivatives and pharmaceutical compositions containing them
09/15/2005WO2005085205A1 Substituted pyrazole compound and herbicide
09/15/2005WO2005085204A1 Process for producing nitrogenous 5-membered cyclic compound
09/15/2005WO2005084392A2 4-methylpyrazole formulations for inhibiting ethanol intolerance
09/15/2005WO2005054204A3 Pharmaceutical compounds that regenerate in vivo
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005044130A9 Pdk-1/akt signaling inhibitors
09/15/2005US20050203295 NO donor has a nitroso group attached to a tertiary carbon; vascular relaxants, nonsteroidal anti-inflammatory drug; water soluble; potentiated by adding glutathione, use low dosage
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050200671 Trisazo dyes for ink jet printing
09/15/2005CA2558109A1 Heteroaryl-fused pyrazolo derivatives
09/15/2005CA2557268A1 Indazole derivatives and pharmaceutical compositions containing them
09/14/2005EP1572665A2 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors
09/14/2005EP1572664A1 Pyrazole compounds
09/14/2005EP1572663A1 Biphenylcarboxamides
09/14/2005EP1572662A1 Pyrazole and imidazole compounds and uses thereof
09/14/2005EP1572200A1 Aminoindazole derivatives and use thereof as kinase inhibitors
09/14/2005EP1572199A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005CN1668602A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
09/14/2005CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors
09/14/2005CN1668595A Method of forming a carbon-carbon or carbon-heteroatom linkage
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/13/2005US6943186 Administering benzopyrazolyl compound for therapy of sepsis
09/13/2005US6943170 N-cycloalkylglycines as HIV protease inhibitors
09/09/2005WO2005082871A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/09/2005WO2005082860A1 Tetracyclines and their use as calpain inhibitors
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005018568A3 Inhibitors of cathepsin s
09/08/2005US20050197371 Urea derivatives as PDGFR modulators
09/08/2005US20050197348 Indazole derivatives as inhibitors of hormone sensitive lipase
09/08/2005US20050197338 Substituted pyrazole urea compounds for the treatment of inflammation
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/07/2005EP1571147A2 Pyrazole analogs acting on cannabinoid receptors
09/07/2005EP1569911A1 Indazole derivatives as crf antagonists
09/07/2005EP1569910A2 Pesticidal sulphonylaminopyrazoles
09/07/2005EP1569909A1 Substituted pyrazoline carboxanilides for use as pesticides
09/07/2005EP1569517A1 Pesticidal 5- (acylamino) pyrazole derivatives
09/07/2005EP1405637B1 Remedies for amyotrophic lateral sclerosis (als)
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/07/2005CN1665793A Ionic liquids
09/07/2005CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
09/07/2005CN1665781A Process for the preparation of phenyl pyrazole compounds
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665475A Merocyanine derivatives for cosmetic use
09/07/2005CN1217946C Process for preparing pyrazolopyrimidinone derivatives for treatment of impotence
09/07/2005CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217928C Heterocyclic compounds having NOS inhibitory activities
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/06/2005US6939382 red shades that contain little blue or yellow
09/01/2005WO2005080379A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005WO2005080361A1 Histamine-3 receptor modulators
09/01/2005WO2005080360A1 Compounds
09/01/2005WO2005080359A1 Benzamide derivatives and their use as glucokinae activating agents
09/01/2005WO2005080344A1 Substituted azole compounds and thereof preparation and application
09/01/2005WO2005080343A2 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
09/01/2005WO2005080317A2 Therapeutic amide derivatives
09/01/2005WO2005079774A2 Management of ophthalmologic disorders, including macular degeneration
09/01/2005WO2005037271A3 Large conductance calcium-activated k channel opener
09/01/2005WO2004085358A8 Process for producing tetraalkoxypropane and derivative thereof
09/01/2005WO2003104189A3 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
09/01/2005US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
09/01/2005US20050192331 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/01/2005US20050192316 Aryl aniline beta2 adrenergic receptor agonists
09/01/2005US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs)
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005DE102004008141A1 Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren Guanidine compounds and their use as binding partners for 5-HT5 receptors
09/01/2005CA2555970A1 Therapeutic amide derivatives
09/01/2005CA2555261A1 Management of ophthalmologic disorders, including macular degeneration
09/01/2005CA2555071A1 Histamine-3 receptor modulators
09/01/2005CA2554894A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2554686A1 Compounds
09/01/2005CA2554310A1 Benzamide derivatives and their use as glucokinase activating agents
09/01/2005CA2498966A1 Novel pyrazole analogs acting on cannabinoid receptors
08/2005
08/31/2005EP1568694A1 N-heteroaryl-para-phenylene diamines for colouring hair
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1567612A1 Electroluminescent materials and devices
08/31/2005EP1567546A2 Aza-peptides
08/31/2005EP1567517A1 Anilinopyrazole derivatives useful for the treatment of diabetes
08/31/2005EP1567504A1 Antibacterial agents
08/31/2005EP1567503A1 Pyrazole derivatives useful as cox-i inhibitors
08/31/2005EP1567151A1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005CN1662507A Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
08/31/2005CN1660033A Composition for dyeing keratinous fibers comprising at least one diamino-n, n-dihydropyrazolone derivative
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 256